ONCO — Onconetix Cashflow Statement
0.000.00%
Last trade - 00:00- $3.10m
- $19.82m
- $0.06m
Annual cashflow statement for Onconetix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.822 | -1.6 | -3.42 | -13.4 | -37.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.003 | 0.335 | 0.154 | 2.18 | 22.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.007 | -0.469 | 1.21 | 2.54 | 1.73 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.825 | -1.73 | -2.04 | -8.7 | -13.6 |
| Capital Expenditures | -0.004 | -0.012 | -0.002 | -0.009 | -6.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -2.51 |
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.004 | -0.012 | -0.002 | -0.009 | -8.65 |
| Financing Cash Flow Items | — | — | -0.334 | -1.77 | -0.205 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.88 | 0 | -0.334 | 32.5 | 1.04 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.05 | -1.74 | -2.38 | 23.8 | -21.2 |